Kinetic determinants of hepatic clearance: Plasma protein binding and hepatic uptake

References

• Abu-Zahra TN, Pang KS. Effect of zonal transport and metabolism on hepatic removal: Enalapril hydrolysis in zonal, isolated rat hepatocytes in vitro and correlation with perfusion data. Drug Metabolism and Disposition 2000; 28: 807–813
   PubMed Web of Science ®Google Scholar
• Akaike A. Posterior probabilities for choosing a regression model. Annals of the Institute of Mathematics and Statistics 1978; 30: A9–A14
   Web of Science ®Google Scholar
• Andersson TB, Bredberg E, Ericsson H, Sjoberg H. An evaluation of the in vitro metabolism data for predicting the clearance and drug–drug interaction potential of CYP2C9 substrates. Drug Metabolism and Disposition 2004; 32: 715–721
   PubMed Web of Science ®Google Scholar
• Andersson TB, Sjoberg H, Hoffmann KJ, Boobis AR, Watts P, Edwards RJ, Lake BG, Price RJ, Renwick AB, Gomez-Lechon MJ, et al. An assessment of human liver-derived in vitro systems to predict the in vivo metabolism and clearance of almokalant. Drug Metabolism and Disposition 2001; 29: 712–720
   PubMed Web of Science ®Google Scholar
• Annaert PP, Turncliff RZ, Booth CL, Thakker DR, Brouwer KL. P-glycoprotein-mediated in vitro biliary excretion in sandwich-cultured rat hepatocytes. Drug Metabolism and Disposition 2001; 29: 1277–1283
   PubMed Web of Science ®Google Scholar
• Austin RP, Barton P, Cockroft SL, Wenlock MC, Riley RJ. The influence of nonspecific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties. Drug Metabolism and Disposition 2002; 30: 1497–1503
   PubMed Web of Science ®Google Scholar
• Austin RP, Barton P, Mohmed S, Riley RJ. The binding of drugs to hepatocytes and its relationship to physicochemical properties. Drug Metabolism and Disposition 2005; 33: 419–425
   PubMed Web of Science ®Google Scholar
• Baba T, Touchi A, Ito K, Yamaguchi Y, Yamazoe Y, Ohno Y, Sugiyama Y. Effects of serum albumin and liver cytosol on CYP2C9- and CYP3A4-mediated drug metabolism. Drug Metabolism and Pharmacokinetics 2002; 17: 522–531
   PubMedGoogle Scholar
• Barter ZE, Bayliss MK, Beaune PH, Boobis AR, Carlile DJ, Edwards RJ, Houston JB, Lake BG, Lipscomb JC, Pelkonen OR, et al. Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: Reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver. Current Drug Metabolism 2007; 8: 33–45
   PubMed Web of Science ®Google Scholar
• Berezhkovskiy LM. Determination of volume of distribution at steady state with complete consideration of the kinetics of protein and tissue binding in linear pharmacokinetics. Journal of Pharmaceutical Science 2004; 93: 364–374
   PubMed Web of Science ®Google Scholar
• Bermejo M, Avdeef A, Ruiz A, Nalda R, Ruell JA, Tsinman O, Gonzalez I, Fernandez C, Sanchez G, Garrigues TM, et al. PAMPA — a drug absorption in vitro model 7. Comparing rat in situ, Caco-2, and PAMPA permeability of fluoroquinolones. European Journal of Pharmaceutical Science 2004; 21: 429–441
   PubMed Web of Science ®Google Scholar
• Bertucci C, Cimitan S. Rapid screening of small ligand affinity to human serum albumin by an optical biosensor. Journal of Pharmacology and Biomedicine Analysis 2003; 32: 707–714
   PubMed Web of Science ®Google Scholar
• Cai Z-S, Burczynski FJ, Luxon BA, Forker EL. On the design and interpretation of experiments to elucidate albumin-dependent hepatic uptake. American Journal of Physiology — Gastrointestinal and Liver Physiology 1992; 261: 61127–61137
   Google Scholar
• Chandra P, Brouwer KL. The complexities of hepatic drug transport: Current knowledge and emerging concepts. Pharmaceutical Research 2004; 21: 719–735
   PubMed Web of Science ®Google Scholar
• Chaturvedi PR, Decker CJ, Odinecs A. Prediction of pharmacokinetic properties using experimental approaches during early drug discovery. Current Opinions in Chemistry and Biology 2001; 5: 452–463
   PubMed Web of Science ®Google Scholar
• Clarke SE, Jeffrey P. Utility of metabolic stability screening: Comparison of in vitro and in vivo clearance. Xenobiotica 2001; 31: 591–598
   PubMed Web of Science ®Google Scholar
• Day YS, Baird CL, Rich RL, Myszka DG. Direct comparison of binding equilibrium, thermodynamic, and rate constants determined by surface- and solution-based biophysical methods. Protein Science 2002; 11: 1017–1025
   PubMed Web of Science ®Google Scholar
• De Buck SS, Sinha VK, Fenu LA, Gilissen RA, Mackie CE, Nijsen MJ. The prediction of drug metabolism, tissue distribution, and bioavailability of 50 structurally diverse compounds in rat using mechanism-based absorption, distribution, and metabolism prediction tools. Drug Metabolism and Disposition 2007; 35: 649–659
   PubMed Web of Science ®Google Scholar
• Forker EL, Luxon BA. Albumin helps mediate removal of taurocholate by rat liver. Journal of Clinical Investigation 1981; 67: 1517–1522
   PubMed Web of Science ®Google Scholar
• Foy BD, Toxopeus C, Frazier JM. Kinetic modeling of slow dissociation of bromosulphophthalein from albumin in perfused rat liver: Toxicological implications. Toxicology Science 1999; 50: 20–29
   PubMed Web of Science ®Google Scholar
• Frostell-Karlsson A, Remaeus A, Roos H, Andersson K, Borg P, Hamalainen M, Karlsson R. Biosensor analysis of the interaction between immobilized human serum albumin and drug compounds for prediction of human serum albumin binding levels. Journal of Medial Chemistry 2000; 43: 1986–1992
   PubMed Web of Science ®Google Scholar
• Gray MR, Tam YK. The series-compartment model for hepatic elimination. Drug Metabolism and Disposition 1987; 15: 27–31
   PubMed Web of Science ®Google Scholar
• Hagenbuch B, Scharschmidt BF, Meier PJ. Effect of antisense oligonucleotides on the expression of hepatocellular bile acid and organic anion uptake systems in Xenopus laevis oocytes. Biochemistry Journal 1996; 316: 901–904
   PubMed Web of Science ®Google Scholar
• Hallifax D, Houston JB. Uptake and intracellular binding of lipophilic amine drugs by isolated rat hepatocytes and implications for prediction of in vivo metabolic clearance. Drug Metabolism and Disposition 2006; 34: 1829–1836
   PubMed Web of Science ®Google Scholar
• Hassen AM, Lam D, Chiba M, Tan E, Geng W, Pang KS. Uptake of sulfate conjugates by isolated rat hepatocytes. Drug Metabolism and Disposition 1996; 24: 792–798
   PubMed Web of Science ®Google Scholar
• Hewitt NJ, Lechon MJ, Houston JB, Hallifax D, Brown HS, Maurel P, Kenna JG, Gustavsson L, Lohmann C, Skonberg C, et al. Primary hepatocytes: Current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies. Drug Metabolism Reviews 2007; 39: 159–234
   PubMed Web of Science ®Google Scholar
• Hill WG, Southern NM, MacIver B, Potter E, Apodaca G, Smith CP, Zeidel ML. Isolation and characterization of the Xenopus oocyte plasma membrane: A new method for studying activity of water and solute transporters. American Journal of Physiology and Renal Physiology 2005; 289: F217–F224
   Web of Science ®Google Scholar
• Horie T, Mizuma T, Kasai S, Awazu S. Conformational change in plasma albumin due to interaction with isolated rat hepatocyte. American Journal of Physiology 1988; 254: G465–G470
   PubMed Web of Science ®Google Scholar
• Ito K, Houston JB. Prediction of human drug clearance from in vitro and preclinical data using physiologically based and empirical approaches. Pharmaceutical Research 2005; 22: 103–112
   PubMed Web of Science ®Google Scholar
• Ito K, Iwatsubo T, Kanamitsu S, Nakajima Y, Sugiyama Y. Quantitative prediction of in vivo drug clearance and drug interactions from in vitro data on metabolism, together with binding and transport. Annual Review of Pharmacology and Toxicology 1998; 38: 461–499
   PubMed Web of Science ®Google Scholar
• Ito K, Suzuki H, Horie T, Sugiyama Y. Apical/basolateral surface expression of drug transporters and its role in vectorial drug transport. Pharmaceutical Research 2005; 22: 1559–1577
   PubMed Web of Science ®Google Scholar
• Iwatsubo T, Hirota N, Ooie T, Suzuki H, Sugiyama Y. Prediction of in vivo drug disposition from in vitro data based on physiological pharmacokinetics. Biopharmaceutics and Drug Disposition 1996; 17: 273–310
   PubMed Web of Science ®Google Scholar
• Kouzuki H, Suzuki H, Ito K, Ohashi R, Sugiyama Y. Contribution of organic anion transporting polypeptide to uptake of its possible substrates into rat hepatocytes. Journal of Pharmacology and Experimental Therapeutics 1999; 288: 627–634
   PubMed Web of Science ®Google Scholar
• Lave T, Coassolo P, Reigner B. Prediction of hepatic metabolic clearance based on interspecies allometric scaling techniques and in vitro–in vivo correlations. Clinical Pharmacokinetics 1999; 36: 211–231
   PubMed Web of Science ®Google Scholar
• Letschert K, Faulstich H, Keller D, Keppler D. Molecular characterization and inhibition of amanitin uptake into human hepatocytes. Toxicology Science 2006; 91: 140–149
   PubMed Web of Science ®Google Scholar
• Li AP, Sakai H, Lu C, Fackett A, Lin JH (2000) Protein binding and metabolism: Effects of human serum albumin on coumarin metabolism in human hepatocytes. Poster presented at the AAPS Annual Meeting. 2000
   Google Scholar
• Liu L, Pang KS. The roles of transporters and enzymes in hepatic drug processing. Drug Metabolism and Disposition 2005; 33: 1–9
   PubMed Web of Science ®Google Scholar
• Liu X, Chism JP, LeCluyse EL, Brouwer KR, Brouwer KL. Correlation of biliary excretion in sandwich-cultured rat hepatocytes and in vivo in rats. Drug Metabolism and Disposition 1999; 27: 637–644
   PubMed Web of Science ®Google Scholar
• Lu C, Li P, Gallegos R, Uttamsingh V, Xia CQ, Miwa GT, Balani SK, Gan LS. Comparison of intrinsic clearance in liver microsomes and hepatocytes from rats and humans: Evaluation of free fraction and uptake in hepatocytes. Drug Metabolism and Disposition 2006; 34: 1600–1605
   PubMed Web of Science ®Google Scholar
• Ludden LK, Ludden TM, Collins JM, Pentikis HS, Strong JM. Effect of albumin on the estimation, in vitro, of phenytoin Vmax and Km values: Implications for clinical correlation. Journal of Pharmacology and Experimental Therapy 1997; 282: 391–396
   PubMed Web of Science ®Google Scholar
• Mizuno N, Niwa T, Yotsumoto Y, Sugiyama Y. Impact of drug transporter studies on drug discovery and development [Review]. Pharmacological Reviews 2003; 55: 425–461
   PubMed Web of Science ®Google Scholar
• Nijssen HM, Pijning T, Meijer DK, Groothuis GM. Influence of albumin on the net sinusoidal efflux of the organic anion dibromosulfophthalein from rat liver. Hepatology 1992; 15: 302–309
   PubMed Web of Science ®Google Scholar
• Nijssen HM, Pijning T, Proost JH, Meijer DK, Groothuis GM. The sinusoidal efflux of dibromosulfophthalein from rat liver is stimulated by albumin, ligandin and fatty acid binding protein but not by other dibromosulfophthalein binding proteins. Journal of Hepatology 1994; 12: 29–36
   Web of Science ®Google Scholar
• Nozawa T, Sugiura S, Nakajima M, Goto A, Yokoi T, Nezu J, Tsuji A, Tamai I. Involvement of organic anion transporting polypeptides in the transport of troglitazone sulfate: Implications for understanding troglitazone hepatotoxicity. Drug Metabolism and Disposition 2004; 32: 291–294
   PubMed Web of Science ®Google Scholar
• Obach RS. Nonspecific binding to microsomes: Impact on scale-up of in vitro intrinsic clearance to hepatic clearance as assessed through examination of warfarin, imipramine, and propranolol. Drug Metabolism and Disposition 1997; 25: 1359–1369
   PubMed Web of Science ®Google Scholar
• Obach RS. Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes. Drug Metabolism and Disposition 1999; 27: 1350–1359
   PubMed Web of Science ®Google Scholar
• Qian D, Brosnan JT. Administration of Escherichia coli endotoxin to rat increases liver mass and hepatocyte volume in vivo. Biochemistry Journal 1996; 313(Pt 2)479–486
   PubMed Web of Science ®Google Scholar
• Rane A, Wilkinson GR, Shand DG. Prediction of hepatic extraction ratio from in vitro measurement of intrinsic clearance. Journal of Pharmacology and Experimental Therapy 1977; 200: 420–424
   PubMed Web of Science ®Google Scholar
• Reasor MJ, Hastings KL, Ulrich RG. Drug-induced phospholipidosis: Issues and future directions. Expert Opinions in Drug Safety 2006; 5: 567–583
   PubMed Web of Science ®Google Scholar
• Rich RL, Day YS, Morton TA, Myszka DG. High-resolution and high-throughput protocols for measuring drug/human serum albumin interactions using BIACORE. Annals in Biochemistry 2001; 296: 197–207
   PubMed Web of Science ®Google Scholar
• Riley RJ, McGinnity DF, Austin RP. A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes. Drug Metabolism and Disposition 2005; 33: 1304–1311
   PubMed Web of Science ®Google Scholar
• Roberts MS, Magnusson BM, Burczynski FJ, Weiss M. Enterohepatic circulation: Physiological, pharmacokinetic and clinical implications. Clinical Pharmacokinetics 2002; 41: 751–790
   PubMed Web of Science ®Google Scholar
• Schwarz G. Estimating the dimension of a model. Annals of Statistics 1978; 6: 461–464
   Web of Science ®Google Scholar
• Shibata Y, Takahashi H, Chiba M, Ishii Y. Prediction of hepatic clearance and availability by cryopreserved human hepatocytes: An application of serum incubation method. Drug Metabolism and Disposition 2002; 30: 892–896
   PubMed Web of Science ®Google Scholar
• Shitara Y, Itoh T, Sato H, Li AP, Sugiyama Y. Inhibition of transporter-mediated hepatic uptake as a mechanism for drug–drug interaction between cerivastatin and cyclosporin A. Journal of Pharmacology and Experimental Therapy 2003; 304: 610–616
   PubMed Web of Science ®Google Scholar
• Siebert GA, Hung DY, Chang P, Roberts MS. Ion-trapping, microsomal binding, and unbound drug distribution in the hepatic retention of basic drugs. Journal of Pharmacology and Experimental Therapy 2004; 308: 228–235
   PubMed Web of Science ®Google Scholar
• Soars MG, Burchell B, Riley RJ. In vitro analysis of human drug glucuronidation and prediction of in vivo metabolic clearance. Journal of Pharmacology and Experimental Therapy 2002; 301: 382–390
   PubMed Web of Science ®Google Scholar
• Soars MG, Grime K, Sproston JL, Webborn PJ, Riley RJ. Use of hepatocytes to assess the contribution of hepatic uptake to clearance in vivo. Drug Metabolism and Disposition 2007a; 35: 859–8605
   PubMed Web of Science ®Google Scholar
• Soars MG, McGinnity DF, Grime K, Riley RJ. The pivotal role of hepatocytes in drug discovery. Chemico-Biology Interactions 2007b; 20(168)2–15
   Web of Science ®Google Scholar
• Sun H, Huang Y, Frassetto L, Benet LZ. Effects of uremic toxins on hepatic uptake and metabolism of erythromycin. Drug Metabolism and Disposition 2004; 32: 1239–1246
   PubMed Web of Science ®Google Scholar
• Tan E, Tirona RG, Pang KS. Lack of zonal uptake of estrone sulfate in enriched periportal and perivenous isolated rat hepatocytes. Drug Metabolism and Disposition 1999; 27: 336–341
   PubMed Web of Science ®Google Scholar
• Tirona RG, Pang KS. Bimolecular glutathione conjugation kinetics of ethacrynic acid in rat liver: In vitro and perfusion studies. Journal of Pharmacology and Experimental Therapeutics 1999; 290: 1230–1241
   PubMed Web of Science ®Google Scholar
• Tirona RG, Tan E, Meier G, Pang KS. Uptake and glutathione conjugation of ethacrynic acid and efflux of the glutathione adduct by periportal and perivenous rat hepatocytes. Journal of Pharmacology and Experimental Therapeutics 1999; 291: 1210–1219
   PubMed Web of Science ®Google Scholar
• Toutain PL, Bousquet-Melou A. Free drug fraction vs free drug concentration: A matter of frequent confusion. Journal of Veterinary and Pharmacological Therapy 2002; 25: 460–463
   PubMed Web of Science ®Google Scholar
• Van de Water FM, Masereeuw R, Russel FG. Function and regulation of multidrug resistance proteins (MRPs) in the renal elimination of organic anions. Drug Metabolism Reviews 2005; 37: 443–471
   PubMed Web of Science ®Google Scholar
• Van den Bongard HJ, Kemper EM, Van Tellingen O, Rosing H, Mathot RA, Schellens JH, Beijnen JH. Development and validation of a method to determine the unbound paclitaxel fraction in human plasma. Analytical Biochemistry 2004; 324: 11–15
   PubMed Web of Science ®Google Scholar
• Van Dyke RW, Faber ED, Meijer DK. Sequestration of organic cations by acidified hepatic endocytic vesicles and implications for biliary excretion. Journal of Pharmacology and Experimental Therapy 1992; 261: 1–11
   PubMed Web of Science ®Google Scholar
• Weisiger RA. Dissociation from albumin: A potentially rate-limiting step in the clearance of substances by the liver. Proceedings of the National Academy of Sciences, USA 1985; 82: 1563–1567
   PubMed Web of Science ®Google Scholar
• Weisiger RA, Pond S, Bass L. Hepatic uptake of protein-bound ligands: Extended sinusoidal perfusion model. American Journal of Physiology 1991; 261: G872–G884
   Google Scholar
• Weisiger RA, Pond SM, Bass L. Albumin enhances unidirectional fluxes of fatty acid across a lipid–water interface: Theory and experiments. American Journal of Physiology 1989; 257: G904–G916
   Google Scholar
• Wright JD, Boudinot FD, Ujhelyi MR. Measurement and analysis of unbound drug concentrations. Clinical Pharmacokinetics 1996; 30: 445–462
   PubMed Web of Science ®Google Scholar
• Yamazaki M, Akiyama S, Nishigaki R, Sugiyama Y. Uptake is the rate-limiting step in the overall hepatic elimination of pravastatin at steady-state in rats. Pharmaceutical Research 1996a; 13: 1559–1564
   PubMed Web of Science ®Google Scholar
• Yamazaki M, Suzuki H, Hanano M, Tokui T, Komai T, Sugiyama Y. Na(+)-independent multispecific anion transporter mediates active transport of pravastatin into rat liver. American Journal of Physiology 1993; 264: G36–G44
   PubMed Web of Science ®Google Scholar
• Yamazaki M, Suzuki H, Sugiyama Y, Iga T, Hanano M. Uptake of organic anions by isolated rat hepatocytes. A classification in terms of ATP-dependency. Journal of Hepatology 1992; 14: 41–47
   PubMed Web of Science ®Google Scholar
• Yamazaki M, Suzuki H, Sugiyama Y. Recent advances in carrier-mediated hepatic uptake and biliary excretion of xenobiotics. [Review]. Pharmaceutical Research 1996b; 13: 497–513
   PubMed Web of Science ®Google Scholar
• Yang J, Jamei M, Yeo KR, Tucker GT, Rostami-Hodjegan A. Theoretical assessment of a new experimental protocol for determining kinetic values describing mechanism (time)-based enzyme inhibition. European Journal of Pharmaceutical Science 2007; 31: 232–234
   PubMed Web of Science ®Google Scholar